PathAI Revenue and Competitors
Estimated Revenue & Valuation
- PathAI's estimated annual revenue is currently $88.8M per year.
- PathAI received $11.0M in venture funding in November 2017.
- PathAI's estimated revenue per employee is $217,000
- PathAI's total funding is $255.2M.
Employee Data
- PathAI has 409 Employees.
- PathAI grew their employee count by -11% last year.
PathAI's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder and CEO | Reveal Email/Phone |
2 | Co-founder and CTO | Reveal Email/Phone |
3 | Chief Staff | Reveal Email/Phone |
4 | COO | Reveal Email/Phone |
5 | Head Talent Acquisition | Reveal Email/Phone |
6 | General Counsel | Reveal Email/Phone |
7 | VP, Biopharma Lab Strategy & Operations | Reveal Email/Phone |
8 | VP Regulatory Affairs | Reveal Email/Phone |
9 | VP, PMO & Platform Product | Reveal Email/Phone |
10 | Head Commercial, Digital Diagnostics | Reveal Email/Phone |
PathAI Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is PathAI?
PathAI's mission is to advance medicine with intelligent pathology. PathAI's platform provides end-to-end data-driven pathology analysis, resulting in fast, accurate and standardized pathologic diagnoses. Research and Drug Development Solutions PathAI's deep-learning solutions drive discovery and predictive diagnostics in drug-development. PathAI's technology accelerates R&D efforts and brings standardization to all phases of the drug development pipeline. Clinical Solutions PathAI is developing clinical decision support tools to improve the clinical workflow and bring increased efficiency, standardization, and clinical insights to diagnostic pathology. Global Health Solutions PathAI is working towards improving health around the globe, by building machine learning applications to provide pathologic diagnoses at a low cost in developing nations. PathAI's goal is to make an enduring impact on patient care by helping hundreds of millions of people receive accurate diagnoses and effective therapies.
keywords:saas
$255.2M
Total Funding
409
Number of Employees
$88.8M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PathAI News
PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the...
The partnership will combine GSK and PathAI's AI and platform engineering teams to scale algorithm development and enable the discovery of new...
PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the...
BOSTON, June 24, 2021 /PRNewswire/ -- PathAI, a global provider of AI-powered technology applied to pathology, today announced the presentation of new data describing improved digital assessment of nonalcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC). These results will ...
BOSTON, June 4, 2021 /PRNewswire/ -- PathAI, a global provider of AI-powered technology applied to pathology, today announced that new data highlighting the application of its ML-based PathR algorithm to clinical trials as an aid to pathologists will be presented in the American Society of Cli ...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $165.1M | 409 | 0% | N/A |
#2 | $300M | 411 | 0% | N/A |
#3 | $138.7M | 411 | -3% | N/A |
#4 | $75M | 415 | 2% | N/A |
#5 | $38.5M | 417 | 28% | $384M |
PathAI Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2017-11-06 | $11.0M | A | General Catalyst Partners | Article |